We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,178.50 +11.00 (+0.21%) Dow Futures
38,308.00 +70.00 (+0.18%) Nasdaq Futures
18,221.50 +42.25 (+0.23%) Russell 2000 Futures
2,030.10 +10.30 (+0.51%) Crude Oil
85.43 -0.23 (-0.27%) Gold
2,371.80 -2.30 (-0.10%)
Health Care Select Sector SPDR Fund (XLV)
After hours:
| Previous Close | 141.01 |
| Open | 140.28 |
| Bid | 138.22 x 900 |
| Ask | 139.04 x 1400 |
| Day's Range | 138.47 - 140.28 |
| 52 Week Range | 122.59 - 148.27 |
| Volume | |
| Avg. Volume | 8,529,353 |
| Net Assets | 41.32B |
| NAV | 138.93 |
| PE Ratio (TTM) | 23.54 |
| Yield | 1.49% |
| YTD Daily Total Return | 2.22% |
| Beta (5Y Monthly) | 0.68 |
| Expense Ratio (net) | 0.09% |
| Inception Date | 1998-12-16 |
Yahoo Finance Video'Continued innovation' is key when investing in weight loss trend
GLP-1 weight-loss drugs' popularity has paved the way for broadening use cases for people seeking a healthier lifestyle; the Food and Drug Administration (FDA) approved Novo Nordisk's (NVO) Wegouvy to use in treating and decreasing overweight patients' elevated cardiac risks. Tema ETFs Chief Investment Officer Yuri Khodjamirian highlights the pharmaceutical trend's ability to mainstream weight-loss treatments and ways to invest in the healthcare space. Khodjamirian's firm manages its own Tema Cardiovascular and Metabolic ETF (HRTS) "It is extremely important that you're selective. The first thing, you need to have a precise exposure of the theme. you want to make sure the companies that are under the hood in the ETFs are the companies that are going to be winning the way forward in terms of forward-looking winners rather than backward-looking winners," Khodjamirian says. "A lot of times you see in ETFs you have the historic winners rather than future ones." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
Yahoo FinanceDaily record highs across the S&P 500 are telling investors this rally is broadening
Despite the "Magnificent Seven" — or three — powering the S&P 500, the long list of companies hitting new record highs shows another side of the market concentration conversation.
Yahoo Finance VideoStocks have been volatile: Here's what has been working
Stocks, so far, are higher for the month of February. But it has been a wild ride, with earnings reports and inflation data causing a lot of volatility. Yahoo Finance's Jared Blikre take a closer look at some of the areas if the market that have been performing well despite the whipsaw market action. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.
Yahoo FinanceThe downside risks hidden in a 'normal' market pullback: Morning Brief
This week saw the stock market's biggest one-day drop — and bounce back. But has anything changed?
Yahoo FinanceHistory shows stocks will still go up even if the 'Magnificent 7' lose steam
A few large tech stocks have been driving the S&P 500, but strategists see a path for further gains even if the market's darlings stop outperforming.
- Yahoo Finance
History suggests stocks are due for a pause as market soars
The S&P 500 is at record highs, but there are historical reasons that point to a potential pause on gains as other sectors catch up to the concentrated few that have been powering the market.
Yahoo Finance VideoDow, S&P 500 extend gains: How global markets are moving
The Dow Jones (^DJI) and the S&P 500 (^GSPC) extend their recent run, with the Dow even on pace to close above a record 38,000 points. Yahoo Finance Markets Reporter Jared Blikre monitors how international market indices are performing year-to-date alongside US markets. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
ZacksHealthcare ETF (XLV) Hit a 52-Week High
The healthcare ETF XLV hit a 52-week high lately. Can it soar higher?
ZacksHealthcare ETFs Start 2024 on a Positive Note
After underperforming in 2023, the healthcare sector seems to be back on track at the start of the New Year. Healthcare generally outperforms during periods of low growth and high uncertainty.
ZacksHealthcare ETF (XLV) Hits New 52-Week High
This healthcare ETF hits a new 52-week high. Are more gains in store for this ETF?
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| XLP Consumer Staples Select Sector SPDR Fund | |||
| XLI Industrial Select Sector SPDR Fund | |||
| XLY Consumer Discretionary Select Sector SPDR Fund | |||
| XLU Utilities Select Sector SPDR Fund | |||
| XLK Technology Select Sector SPDR Fund |